| 2nd May 2014 5:38 pm |
RNS |
Director/PDMR Shareholding |
| 2nd May 2014 5:38 pm |
RNS |
Director/PDMR Shareholding |
| 2nd May 2014 5:34 pm |
RNS |
Director/PDMR Shareholding |
| 2nd May 2014 5:34 pm |
RNS |
Director/PDMR Shareholding |
| 2nd May 2014 5:31 pm |
RNS |
Director/PDMR Shareholding |
| 1st May 2014 12:24 pm |
RNS |
Total Voting Rights |
| 1st May 2014 7:00 am |
RNS |
GSK receives US approval for Incruse Ellipta |
| 30th Apr 2014 12:00 pm |
RNS |
1st Quarter Results |
| 28th Apr 2014 4:11 pm |
RNS |
GSK Receives EU Marketing Authorisation - Incruse |
| 28th Apr 2014 3:36 pm |
RNS |
Director/PDMR Shareholding |
| 22nd Apr 2014 7:01 am |
RNS |
GSK announces major transaction with Novartis |
| 17th Apr 2014 4:58 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2014 4:58 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2014 4:56 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2014 4:56 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2014 4:52 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2014 4:50 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2014 4:50 pm |
RNS |
Director/PDMR Shareholding |
| 17th Apr 2014 4:24 pm |
RNS |
GSK receives approval in Canada for Incruse |
| 15th Apr 2014 5:56 pm |
RNS |
Tanzeum (albiglutide) receives FDA approval |
| 15th Apr 2014 3:39 pm |
RNS |
Director/PDMR Shareholding |
| 15th Apr 2014 3:36 pm |
RNS |
Director/PDMR Shareholding |
| 14th Apr 2014 4:34 pm |
RNS |
Director/PDMR Shareholding |
| 11th Apr 2014 3:17 pm |
RNS |
Director/PDMR Shareholding |
| 11th Apr 2014 3:15 pm |
RNS |
Director/PDMR Shareholding |
| 11th Apr 2014 11:03 am |
RNS |
Director/PDMR Shareholding |
| 10th Apr 2014 3:14 pm |
RNS |
Director/PDMR Shareholding |
| 10th Apr 2014 3:12 pm |
RNS |
Director/PDMR Shareholding |
| 8th Apr 2014 4:11 pm |
RNS |
Director/PDMR Shareholding |
| 8th Apr 2014 4:10 pm |
RNS |
Director/PDMR Shareholding |
| 2nd Apr 2014 10:52 am |
RNS |
Director/PDMR Shareholding |
| 2nd Apr 2014 7:00 am |
RNS |
Update on Phase lll clinical trial of MAGE-A3 |
| 31st Mar 2014 3:16 pm |
RNS |
Director/PDMR Shareholding |
| 31st Mar 2014 7:00 am |
RNS |
GSK data from PIII STABILITY study of darapladib |
| 26th Mar 2014 1:07 pm |
RNS |
Eperzan (albiglutide) receives EMA approval |
| 26th Mar 2014 10:17 am |
RNS |
Notice of AGM |
| 26th Mar 2014 10:07 am |
RNS |
Regulatory update on combined use of MEK/BRAF |
| 24th Mar 2014 9:56 am |
RNS |
Director/PDMR Shareholding |
| 21st Mar 2014 11:32 am |
RNS |
GSK - historical restated financial information |
| 20th Mar 2014 7:00 am |
RNS |
MAGE-A3 MAGRIT Phase III trial results |
